ArticleJAMIA open2024
Implementation of a rule-based algorithm to find patients eligible for cancer clinical trials.
Article in JAMIA open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05146297 (Diversity and Inclusion in Research Underpinning Trials), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Diversity and Inclusion in Research Underpinning Trials
Who cites it
4 citing papers in PubMed.
- AI-based augmentation of oncology clinical trials.Nature reviews. Clinical oncology · 2026Review
- Developing and Evaluating a Natural Language Processing Algorithm to Detect Insulin Pump and Continuous Glucose Monitor Use in Electronic Health Records of Patients with Type 1 Diabetes.Diabetes technology & therapeutics · 2026Article
- Large language model derived regular expressions for sleep phenotyping from electronic health record: a feasibility study.Sleep advances : a journal of the Sleep Research Society · 2026Article
- Recommending Clinical Trials for Online Patient Cases using Artificial Intelligence.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore implementing regular expressions (RegEx) to streamline patient identification and classification for matching to clinical trials. Materials and Methods: To prepare approaches needed to match patients to relevant cancer clinical trials, we combined NCI's Clinical Trials Search API to extract high-level eligibility criteria, including cancer type, stage, receptor/biomarker status, with similar data of patients with appointments in the upcoming week. Using RegEx, we prospectively identified all patients with breast, liver, or lung cancers at treatment decision points at 2 Cancer Centers' and 2 community hospitals', classified their cancer type, stage, and receptor/biomarker status. We evaluated accuracy using RegEx against manual reviews. Results: Algorithm accuracy to identify patients at treatment decision points revealed 92% True Negative and 53% True Positive rate. Staging accuracy varied from 67% to 95%, and receptor/biomarker status accuracy from 76% to 86%. Discussion and Conclusion: Using RegEx significantly reduced the number of patients requiring manual review, demonstrating a reduction in manual labor and potential biases, which can improve efficiency and inclusivity of clinical trial enrollment processes, especially in resource limited or data sensitive environments. Trial Registration: NCT05146297.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.